• Latest Posts

Adaptimmune to Take Off-The-Shelf CAR-T to Phase I with Astellas

Interview 11 Sep 2018

How To Break Into The Crowded Immuno-Oncology Space

Adaptimmune Gets the Green Light for its New T-cell Cancer Therapy


GSK wants in on Adaptimmune’s Adaptable T cell Cancer Treatment

Interview 20 Apr 2017

Which EU Immuno-Oncology Company are you Cheering for?

Infographics 13 Feb 2017

Infographic: What’s in Europe’s Immuno-oncology Pipeline?

The 8 Biggest Biotech Medical Fails of 2016 in Europe

UPDATE: FDA Lifts Hold on Adaptimmune’s Rare Cancer Trials